Tottenham Hotspur manager, Antonio Conte is set for a bit of a spell on the sidelines as he undergoes surgery for Cholecystitis.
Tottenham announced that the Italian is going to have his gallbladder removed in a surgery today, but what is this condition he is suffering from?
Let’s take a look at what Cholecystitis is as Conte goes under the knife.

What is Cholecystitis?
Simply put, Cholecystitis is an inflammation of the gallbladder, which is a small pear-shaped organ located in the right upper abdomen.
The gallbladder stores bile, a digestive fluid produced by the liver, which helps break down fats in the small intestine.
Cholecystitis is sometimes caused by the formation of gallstones, which can become stuck in the narrow tubes that connect the gallbladder and the liver, blocking the flow of bile.
Gallstones are very common, affecting about 1 in 10 adults in the UK.
The accumulation of bile can cause inflammation and sometimes infection in the gallbladder, leading to pain, fever, and discomfort.
In some cases, infection can spread to the surrounding tissues, but luckily, it doesn’t seem as though this is the case with Conte.
Cholecystitis can be treated with antibiotics and pain relief medications, but in this case, surgery is required to remove the gallbladder.
This procedure, called a cholecystectomy, is commonly performed and has a high success rate.
According to the NHS website. This surgery can be done in three ways.
A laparoscopic cholecystectomy – a type of keyhole surgery where the gallbladder is removed using special surgical instruments inserted through a number of small cuts in your abdomen.
A single-incision laparoscopic cholecystectomy – where the gallbladder is removed through a single cut, which is usually made near the bellybutton.
An open cholecystectomy – where the gallbladder is removed through a single larger cut in the tummy.
This condition shouldn’t affect Conte in the long-term, and hopefully he’ll be back on the touchline for Spurs sooner rather than later.
Receive exclusive football transfer news and updates twice a week to your mailbox
